Stopping routine vaccination for tuberculosis in schools.

I Hill P. Ofl'Iicense and oil label prescribing in children: litigation fears for physicians. Arch Do Child 2005;90:17-5. 2 Conroy S. Choonara 1, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries BAf/ 2000; 320:7 9-52. 3 McIntyre I, Conroy 5, Avery A, Corns H, Choonara I Unlicensed and off lapel prescribing of drugs in general practice. Arch Di.r GhO1a 2000;83: 495-501 4 Chalumcau M, TrSluyer JM, Salanave B, Assathiany R, Cheiron G, Cra:heton N, et al. Off label and unlicensed drug rise among French office based paediatricians. Arch Dr y Child 2000;83:502-5. 5 't Jong \s Eland ]A, Sturkenhoom MC(M, van den Anmer JN, Stricker TiHCh. Unlicensed and of]' label prescription of drugs to children: 1?opulation based c ohor t sandy: JIM/2002i321 :1313-1. 0 O'Donnell CP, Stone Rl, Morley CJ. Unlicensed and of]-label drug use in an Australian neonatal intensive care unit [ edufrics 2002;1 ]0:e52. 7 Neuhert A, Dormann H, Weiac J, Egger T Criegee-Rierk M, Rascher W, et at The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients UnugSafely 2004;27:1059-67. B Medicines for children. European Commission proposal for regulation of the Council and of the Parliament on medicinal products for paediatric use, 29 September 2004. http://phannanneudraorg/F2/ Paediatrics/indexhtm (accessed 30 Ang 2005). B European Medicines Agency. Guideline on conduct of pharmatovigilance for medicines used by the paediatric population. 27 Iuly 2005. Htvwemeaeu.int/prlft/human/phvwp/2iâ591005en.lxlt' (accessed 30 Aug 2005). 10 US Food and Drug Administration. Pediatric Research Equity Act of 2003. www.frla.goc/opacom/IaHs/prea.html (accessed 30 .Aug 2005). 11 Costello ], ecL JiN' fi r Children. London: Pharmaceutical Press, 2005.